Biomarkers (1)
- af_status - AF status (phv00427046.v1.p1)
Demographics (1)
- sex - Gender of participant (phv00427047.v1.p1)
Race and Ethnicity (1)
- race - Race of participant (phv00427048.v1.p1)
Other (15)
- ANALYTE_TYPE - Analyte Type (phv00427051.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00427050.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00427041.v1.p1)
- Funding_Source - Project funding source (phv00427054.v1.p1)
- IS_TUMOR - Tumor status (phv00427052.v1.p1)
- SAMPLE_ID - Sample ID (phv00427049.v1.p1)
- SAMPLE_ID - Sample ID (phv00427044.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00427053.v1.p1)
- SEX - Genetic Sex (phv00530956.v1.p1)
- Study_Name - TOPMed-assigned short study name (1:1 with TOPMed phs number) (phv00427057.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00427045.v1.p1)
- SUBJECT_ID - Subject ID (phv00427040.v1.p1)
- SUBJECT_ID - Subject ID (phv00427043.v1.p1)
- TOPMed_Phase - TOPMed Phase (phv00427055.v1.p1)
- TOPMed_Project - TOPMed Project that funded sequencing (phv00427056.v1.p1)